1.0Business France at BIO Conventionhttps://event.businessfrance.fr/business-france-at-bio-conventionrich600338<blockquote class="wp-embedded-content" data-secret="UcTmQtXEYW"><a href="https://event.businessfrance.fr/business-france-at-bio-convention/hemerion-therpeutics/">Hemerion Therapeutics</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://event.businessfrance.fr/business-france-at-bio-convention/hemerion-therpeutics/embed/#?secret=UcTmQtXEYW" width="600" height="338" title="« Hemerion Therapeutics » — Business France at BIO Convention" data-secret="UcTmQtXEYW" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://event.businessfrance.fr/business-france-at-bio-convention/wp-includes/js/wp-embed.min.js </script> https://event.businessfrance.fr/business-france-at-bio-convention/wp-content/uploads/sites/1378/2026/04/Design-sans-titre-52.png13501350HEMERION Therapeutics is a clinical-stage healthcare company focused on the discovery and development of innovative therapies that combine photosensitizing molecules and laser light technologies. This combination product strategy is aimed at the selective treatment of resistant tumors. More specifically, the company is positioned in oncology and has dedicated its first "best-in-class" drug-device combination program to target glioblastoma as its first indication. Hemerion's technology is based on the unprecedented combination of a photosensitizing drug and an innovative photonic device.